GB0218234A
GB0218234D0
(en)
|
2002-08-06 |
2002-08-06 |
Antibodies
|
AR20030102790A
AR040778A1
(en)
|
2002-08-06 |
2003-08-04 |
ALTERED ANTIBODIES OR FUNCTIONAL FRAGMENTS THAT BIND MAG (GLICOPROTEIN ASSOCIATED WITH HONEY).
|
TW092121286A
TWI323265B
(en)
|
2002-08-06 |
2003-08-04 |
Antibodies
|
JP2004526901A
JP4528121B2
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin-related glycoprotein (MAG) antibody
|
US10/523,295
US7612183B2
(en)
|
2002-08-06 |
2003-08-05 |
Humanised anti-mag antibody or functional fragment thereof
|
CNB03818477XA
CN100542607C
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (MAG) antibody
|
BR0312456-8A
BR0312456A
(en)
|
2002-08-06 |
2003-08-05 |
Altered antibody or functional fragment thereof, polynucleotide, polynucleotide sequence, pharmaceutical composition, methods of treatment or prophylaxis of stroke and other neurological diseases / disorders in a human, inhibiting neurodegeneration and / or promoting functional recovery and promoting axonal development, and use of an anti-mag antibody
|
PT37841954T
PT1526868E
(en)
|
2002-08-06 |
2003-08-05 |
Anti-mag humanised antibodies and their uses for treating stroke
|
DK03784195.4T
DK1526868T3
(en)
|
2002-08-06 |
2003-08-05 |
HUMANIZED ANTI-MAG ANTIBODIES AND THEIR APPLICATIONS FOR TREATING CASES
|
MYPI20032945A
MY148409A
(en)
|
2002-08-06 |
2003-08-05 |
Anti-mag antibodies
|
AU2003255390A
AU2003255390B2
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (MAG) antibodies
|
SI200332328T
SI1526868T1
(en)
|
2002-08-06 |
2003-08-05 |
Anti-mag humanised antibodies and their uses for treating stroke
|
PL375405A
PL211014B1
(en)
|
2002-08-06 |
2003-08-05 |
Antibodies
|
CA2494008A
CA2494008C
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (mag) antibodies
|
PCT/EP2003/008749
WO2004014953A2
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (mag) antibodies
|
NZ537123A
NZ537123A
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (MAG) antibodies and the use thereof to treat stroke and other neurological disorders
|
KR1020057002132A
KR101078459B1
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoproteinmag antibodies
|
IL16547803A
IL165478A0
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated ghycoprotein (MAG) antibodies
|
EP03784195.4A
EP1526868B1
(en)
|
2002-08-06 |
2003-08-05 |
Anti-mag humanised antibodies and their uses for treating stroke
|
ES03784195.4T
ES2440652T3
(en)
|
2002-08-06 |
2003-08-05 |
Humanized anti-MAG antibodies and their uses for stroke treatment
|
MXPA05001468A
MXPA05001468A
(en)
|
2002-08-06 |
2003-08-05 |
Anti-myelin associated glycoprotein (mag) antibodies.
|
IL165478A
IL165478A
(en)
|
2002-08-06 |
2004-11-30 |
Humanized anti-myelin associated glycoprotein (mag) antibody and pharmaceutical composition comprising such antibody
|
IS7576A
IS7576A
(en)
|
2002-08-06 |
2004-11-30 |
Anti-myelin-linked glycoprotein (MAG) antibodies
|
NO20045323A
NO333876B1
(en)
|
2002-08-06 |
2004-12-03 |
Humanized antibody as well as pharmaceutical preparation.
|
HK05109282.3A
HK1077206A1
(en)
|
2002-08-06 |
2005-10-20 |
Anti-mag humanised antibodies and their uses for treating stroke
|
US12/060,555
US8071731B2
(en)
|
2002-08-06 |
2008-04-01 |
Humanised anti-MAG antibody or functional fragment thereof
|
CY20141100027T
CY1114919T1
(en)
|
2002-08-06 |
2014-01-14 |
ANTI-MAG MANUFACTURED ANTIBODIES AND THEIR USES FOR TREATMENT OF THE Cerebral Palsy
|